Transmedics Group Stock Today
| TMDX Stock | USD 87.11 6.50 8.06% |
Performance0 of 100
| Odds Of DistressLess than 25
|
TransMedics is trading at 87.11 as of the 28th of November 2024; that is 8.06 percent increase since the beginning of the trading day. The stock's open price was 80.61. TransMedics has about a 25 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for TransMedics Group are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company was founded in 1998 and is headquartered in Andover, Massachusetts. The company has 33.56 M outstanding shares of which 8.43 M shares are at this time shorted by private and institutional investors with about 4.25 trading days to cover. More on TransMedics Group
Moving together with TransMedics Stock
Moving against TransMedics Stock
TransMedics Stock Highlights
TransMedics Group (TMDX) is traded on NASDAQ Exchange in USA. It is located in 200 Minuteman Road, Andover, MA, United States, 01810 and employs 584 people. TransMedics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.71 B. TransMedics Group conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 33.56 M outstanding shares of which 8.43 M shares are at this time shorted by private and institutional investors with about 4.25 trading days to cover.
TransMedics Group currently holds about 204.46 M in cash with (13.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.41.
Check TransMedics Probability Of Bankruptcy
Ownership AllocationThe majority of TransMedics Group outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in TransMedics to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in TransMedics Group. Please pay attention to any change in the institutional holdings of TransMedics Group as this could imply that something significant has changed or is about to change at the company.
Check TransMedics Ownership Details
TransMedics Group Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. TransMedics market risk premium is the additional return an investor will receive from holding TransMedics long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.88) | |||
| Total Risk Alpha | (1.66) | |||
| Treynor Ratio | 61.64 |
TransMedics Stock Against Markets
TransMedics Corporate Management
| Miriam Provost | Vice Affairs | Profile | |
| Mark Anderson | Senior Development | Profile | |
| Susan Goodman | Vice Resources | Profile | |
| John Carey | VP Operations | Profile | |
| Nick Corcoran | Senior Operations | Profile | |
| Tamer MD | Chief Officer | Profile |
Additional Tools for TransMedics Stock Analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.